This week, the U.S. Court of Appeals for the District of Columbia provided some much-needed guidance about attorney-client privilege to general counsel whose roles as businesspeople often blur with their legal responsibilities.

On Tuesday, the federal appellate court upheld a lower court ruling that certain files belonging to Boehringer Ingelheim Pharmaceuticals Inc. and requested by the Federal Trade Commission are protected by the attorney-client privilege and thus do not have to be turned over to the agency.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]